• WAY-100635 in Pain-Circuit Mechanism Studies

  2026-09-22

  WAY-100635 is a selective 5-HT1A antagonist for dissecting serotonin-dependent pain, affective, and circuit mechanisms. This article shows how to use it as a causal pharmacology tool alongside multimodal cannabidiol pain assays, while separating established evidence from testable hypotheses.

• Standardized Whole-Blood Stimulation and Immunometabolism

  2026-09-22

  Zhao and colleagues present a standardized whole-blood stimulation protocol that integrates pathogen-relevant immune challenges with pharmacological metabolism modulation and cytokine measurement. The workflow offers a practical framework for comparing donor responses while examining how anabolic and catabolic pathways selectively shape immune signaling.

• (5Z)-7-Oxozeaenol: TAK1 Assay Guide

  2026-09-21

  This scenario-based guide explains how (5Z)-7-Oxozeaenol, SKU B7443, can improve interpretation of viability, proliferation, and inflammatory signaling experiments. It connects TAK1 inhibition with NF-κB, JNK/p38 MAPK, COX-2, and the AMPK–SQSTM1 stress-adaptation circuit while emphasizing solvent control, timing, and product-handling decisions.

• SB-3CT Gelatinase Inhibitor Workflows

  2026-09-21

  SB-3CT is a mechanism-based gelatinase inhibitor for separating MMP-2/MMP-9 activity from broader extracellular-matrix remodeling. This workflow-focused guide connects perineuronal-net assays with tumor metastasis research, angiogenesis inhibition, and neuroprotection in cerebral ischemia while emphasizing exposure control and interpretation limits.

• EdU Cell Proliferation Kit for RA S-Phase Studies

  2026-09-20

  Use the EdU Cell Proliferation Kit (TMB) to quantify DNA synthesis in rheumatoid arthritis fibroblast-like synoviocytes and other proliferating cell models without radioactivity. Its EdU–biotin click-chemistry workflow connects cell cycle S-phase detection with practical drug-response, genotoxicity, and pathway-validation experiments.

• Calcitriol in NFIA Bone Remodeling Research

  2026-09-19

  Calcitriol and 1,25-dihydroxy vitamin D3 can serve as mechanistic perturbagens in bone-remodeling assays. This guide connects vitamin D receptor signaling with new NFIA findings to improve experimental design, interpretation, and translational relevance.

• Biotin-tyramide: Reliable TSA for Cell Assays

  2026-09-18

  This scenario-based guide explains how Biotin-tyramide (SKU A8011) can strengthen spatial detection in viability, proliferation, and cytotoxicity workflows without being mistaken for a primary viability readout. It covers mechanism, experimental controls, solvent handling, interpretation, and vendor-selection criteria using product specifications and a relevant proximity-labeling study.

• SW033291: 15-PGDH Inhibitor Workflows

  2026-09-18

  SW033291 connects controlled prostaglandin E2 elevation with practical assays for hematopoiesis, stem-cell behavior, and tissue repair. This guide translates 15-PGDH inhibition into reproducible enzyme, bone-marrow, and muscle-regeneration workflows while emphasizing controls, compound handling, and preclinical limitations.

• WAY-100635: A Causal Lens on 5-HT1A Pain Biology

  2026-09-17

  WAY-100635 provides a selective pharmacological test of 5-HT1A signaling across receptor, circuit, and behavioral assays. This article shows how to use it to interpret cannabidiol pain research without confusing serotonergic association with causal evidence.

• Obeticholic Acid: FXR Workflows for Fibrosis

  2026-09-17

  Obeticholic Acid provides a defined FXR-centered workflow for bile acid regulation, cholestasis, and liver fibrosis research. This guide connects dose-finding, gene-expression readouts, and orthogonal fibrosis assays while distinguishing FXR biology from the Notch and NK-cell mechanisms reported in recent liver research.

• Vitamin D/VDR Signaling in Endometrial Decidualization

  2026-09-16

  The reference study identifies vitamin D receptor (VDR) signaling as a direct regulator of human endometrial stromal-cell decidualization. Its combination of metabolic profiling, VDR perturbation, estrogen-pathway analysis, and promoter-occupancy assays links 1,25-dihydroxy vitamin D3 to CYP19- and ESR1-associated remodeling of the endometrial estrogen environment.

• (-)-Blebbistatin for Cardiac Mechanobiology

  2026-09-16

  Learn how to use (-)-Blebbistatin as a reversible non-muscle myosin II inhibitor for separating cytoskeletal mechanics from temperature-sensitive cardiac electrophysiology. The workflow combines controlled dosing, thermal challenge, live-cell readouts, and troubleshooting guidance for mechanobiology and cardiac research.

• Parathyroid hormone (1-34) (human) for Assays

  2026-09-15

  Use this defined PTH (1-34) peptide fragment to connect receptor-proximal signaling with bone metabolism research and spatial kidney assembloid studies. The workflow combines activity benchmarks, controlled exposure designs, and troubleshooting guidance for reproducible calcium-related assays.

• Quaternization Reprograms Lung-Targeted mRNA Delivery

  2026-09-15

  The 2024 Theranostics study shows that N-quaternization of the lipid-like carrier tB-UC18 converts mRNA-loaded nanoassembly tropism from the spleen to the lung after intravenous administration. The qtB-UC18/DOPE system produced highly selective pulmonary translation, highlighting head-group chemistry as a practical design variable for non-liver mRNA delivery.

• Demethyleneberberine: An Assay-First Guide

  2026-09-14

  Demethyleneberberine (DMB) is a multipathway research compound whose value depends on matching concentration, model, and mechanistic readouts. This assay-first guide explains how to interpret its autoimmune hepatitis evidence and extend it responsibly to inflammation, NSCLC, and neuroprotection studies.

8630 records 1/576 page Next 12345 下5页 Last page